Matt Henriksson
speaker
103 appearances
1 recordings
1 series
first heard Feb 2026
last heard 12 Feb
Matt Henriksson’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Feb 2026 with 1.
Appearances
And let's dive into that because, you know, I think, well, my initial perception of AliveCore was a, you know,
after the, almost an after the fact, and it's a long-term follow-up.
And I believe my understanding is that was the CardiaMobile 6L device, but now you're bringing in this Cardia 12L, which is going to be in the physician's office that allows then that physician, like you said, almost to use it like a stethoscope in his pocket and bring it out.
Is that the right way to
Envision how those two technologies play out together.
Well, I actually just I took the information that you just gave me.
So that's always great.
So let's talk about the Cardia 12 L then, because that seems to be the most recent catalyst.
And you talked about 39 determinations.
I just also remember that there was earlier this month or last month, there was a new FDA clearance for five new cardiac determinations.
Is that included in that 39 now?
Yeah.
How important is those five for the new 39?
And, you know, 39 is a lot of kids to have.
But I'm curious, out of those 39, which ones are your favorite children?
Yeah, and that seems very important, too, when you think about, you know, MI or myocardial infarction cases is that you want to treat that as quickly as possible.
And being able to get that in the first step instead of having to go through additional steps of testing and screening and everything seems like a very important step for those patients.
Yeah.
And so we talk about some of the other clinical data.
And, you know, there's over, you know, on your website, I noticed 170 peer-reviewed articles.
Showing 21–40 of 103 · page 2 of 6
← Previous
Next →